Drug Database
Back to search

France· FR:63572025

BETAGAN 0,5 % , collyre en solution en récipient unidose

A levobunolol product containing chlorhydrate de lévobunolol, registered in France by ABBVIE, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC S01ED03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBETAGAN 0,5 % , collyre en solution e…ATCS01ED03REGISTER NO.FR:63572025PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de lévobunololAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levobunolol is registered in 8 of 19 countries.

Countries holding a registration under ATC S01ED03 (levobunolol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose
Search levobunolol products by name

Levobunolol · ATC S01ED03

8 / 19 countries

  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE LÉVOBUNOLOL
Manufacturer
ABBVIE
Country
France (FR)
ATC code
S01ED03
ATC class
Levobunolol
Defined daily dose
0.2 ml, AT
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400934586101
    60 récipient(s) unidose(s) polyéthylène de 0,4 ml
    EUR 6.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

127 interactions on record for levobunolol.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levobunolol against other medicinesHow interaction checks work

Levobunolol · interactions on record

127 records

  • 26 severe
  • 68 moderate
  • 2 minor
  • 31 info

Most severe, free to view

  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • TheophyllinC01EB28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levobunolol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levobunolol products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Italy · Vistagan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0beca897-38c2-4cef-a2e5-515b3d83a076
GET /v1/drugs/0beca897-38c2-4cef-a2e5-515b3d83a076?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63572025",
  "date_amm": "1997-01-06",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE LÉVOBUNOLOL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "collyre en solution",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about levobunolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console